The Shield MCD test screens for 10 of the most common cancers — bladder, colorectal, breast, prostate, esophageal, gastric, liver, lung, ovarian, and pancreatic — with just a blood draw.
The budget outlines support for new insurance solvency rules and greater disclosure standards, but focus on growth sectors—such as low-altitude aviation and autonomous vehicles—will bring new opportunities...
The scheme shifts Religare’s lending, broking, and investment operations into Religare Finvest, with a separate listing targeted for Q1 FY28, subject to approvals.
The renewed Grievance Mechanism Committee (GMC) will bring together medical, hospital, insurance and takaful associations to identify and improve systemic challenges in medical claims.
